Arcturus Therapeutics Holdings Inc.
ARCTBiotechnology
$11.03−9.22%As of Oct 30vs prior close
- Market cap
- $313.5M
- P/E (TTM)
- –
- From 52W high
- −34.85%
- EPS (LTM)
- -$3.33
- Revenue (LTM)
- $29.4M
- Net margin
- -317.61%
- Dividend yield
- 0.00%
Nomior Score
35
Steady ProfileBottom 21% of the scored universe
Growth46
Quality36
Value43
Momentum53
Resilience30
Growth
+26.58%revenue a year over 7 fiscal years
YE18 $15.8MLTM $29.4M
Connections
Revenue to profitQ2 YE26
The operating loss was 863% of revenue, wider by 822 pts on a year.
Who owns it
2funds